HealthEquity News

HealthEquity Analyst Ratings

BenzingaJul 3 09:16 ET

Maintaining Buy Rating on Healthequity Amid Limited Impact Security Incident

TipRanksJul 3 06:22 ET

HealthEquity Analyst Ratings

BenzingaJun 20 08:43 ET

HealthEquity Analyst Ratings

BenzingaJun 7 13:02 ET

HealthEquity Analyst Ratings

BenzingaJun 4 07:44 ET

Bank of America Securities Keeps Their Buy Rating on Healthequity (HQY)

TipRanksMay 31 09:24 ET

HealthEquity: Strong Market Position and Positive Outlook Reinforce Buy Rating

TipRanksMay 16 12:41 ET

Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Cellectis SA (CLLS) and Idexx Laboratories (IDXX)

TipRanksApr 30 05:41 ET

Analysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX), Healthequity (HQY) and Nuvation Bio (NUVB)

TipRanksApr 17 06:35 ET

HealthEquity Analyst Ratings

BenzingaApr 4 04:57 ET

HealthEquity's Market Leadership and Growth Trajectory Bolster Buy Rating

TipRanksApr 4 00:42 ET

HealthEquity Analyst Ratings

BenzingaApr 2 10:32 ET

HealthEquity Poised for Strong Growth: Buy Rating With a $108 Price Target

TipRanksApr 2 05:12 ET

Jefferies Adjusts HealthEquity Price Target to $95 From $79, Maintains Buy Rating

MT NewswiresMar 28 09:16 ET

Jefferies Keeps Their Buy Rating on Healthequity (HQY)

TipRanksMar 28 08:07 ET

Buy Rating on Healthequity (HQY) Affirmed Amid HSA Market Growth and Competitive Outperformance

TipRanksMar 28 05:01 ET

Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Aerovate Therapeutics (AVTE) and Delcath Systems (DCTH)

TipRanksMar 27 06:15 ET

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Healthequity (HQY) and Bluebird Bio (BLUE)

TipRanksMar 26 20:05 ET

HealthEquity Analyst Ratings

BenzingaMar 22 11:11 ET

HealthEquity Outperforms With Strong Quarterly Results and Positive Fiscal 2025 Outlook: Buy Rating Reaffirmed

TipRanksMar 22 09:20 ET